[ad_1]
Ligand Pharmaceuticals (NASDAQ:LGND) Sets New 1-Year High After Analyst Upgrade
[ad_2]
Source link
Related Posts
Ousted FDA vaccine chief Vinay Prasad is returning to the agency
[ad_1] WASHINGTON (AP) — A Food and Drug Administration official is getting his job back as the agency’s top vaccine…
Invesco Ltd. Has $8.50 Million Holdings in NIO Inc. $NIO
[ad_1] Invesco Ltd. cut its position in shares of NIO Inc. (NYSE:NIO – Free Report) by 3.3% in the 1st…
B. Riley Issues Positive Forecast for Cytokinetics (NASDAQ:CYTK) Stock Price
[ad_1] B. Riley raised their price target on Cytokinetics from $74.00 to $80.00 and gave the stock a “buy” rating…